Live feed16:08:43·102dINSIDERFilingvia QuantisnowEVP Chief R&D Garg Pushkal converted options into 1,908 shares and sold $1,533,100 worth of shares (4,627 units at $331.34), decreasing direct ownership by 11% to 22,129 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.ALNY· Alnylam Pharmaceuticals Inc.Health CareOriginal source